Equity in cancer drug access in the UK

1 February 2022 - In draft guidance published on 5 January 2022, NICE announced their decision not to recommend the use ...

Read more →

Modifying NICE’s approach to equity weighting

7 February 2021 - The UK’s NICE recently launched a consultation on the methods it uses to evaluate new health technologies, ...

Read more →

Redistribution and redesign in health care: an ebbing tide in England versus growing concerns in the United States

4 May 2017 - Like many countries, the health care industries of England  and the United States consume large amounts ...

Read more →